Evaluation of Sodium Bicarbonate to Reduce the Incidence of Contrast Induced Chronic Kidney Injury in Patients With Kidney Disease

A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 391 participants.

Also called NCT00930436

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 391 participants (enrolled count) (from the registry)
Sponsor
MD Scientific (from the registry)
Registry
  • NCT NCT00930436
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT00930436. Randomized; quadruple masking; primary purpose prevention. Start 2010-01 (registry gives no type); primary completion 2012-08 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluation of Sodium Bicarbonate to Reduce the Incidence of Contrast Induced Chronic Kidney Injury in Patients With Kidney Disease
Acronym
BOSS
Condition
Contrast Induced Kidney Injury.
Intervention (Drug)
sodium bicarbonate
Lead sponsor
MD Scientific (class: industry)

Record details

Record id
cardio:ct-nct00930436
Content hash
a15cf6b2f105a1fc4b9c0f189935ae4b20aea90c056465529ae37dd6fe9bd211